2018
DOI: 10.1155/2018/3963274
|View full text |Cite
|
Sign up to set email alerts
|

Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis

Abstract: Context Pheochromocytomas are hormone secreting tumors of the medulla of the adrenal glands found in 0.1–0.5% of patients with hypertension. The vast majority of pheochromocytomas secrete catecholamines, but they have been occasionally shown to also secrete interleukins, calcitonin, testosterone, and in rare cases adrenocorticotropic hormone. Pheochromocytoma crisis is a life threatening event in which high levels of catecholamines cause a systemic reaction leading to organ failure. Case Description A 70-year-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 14 publications
1
5
0
1
Order By: Relevance
“…Similar presentations of hypertension, refractory to treatment, with Cushingoid features have been reported previously. 2,6,7 Phaeochromocytoma was suspected by unilaterally elevated levels of methoxycatecholamines on AVS but confirmed through immunohistochemistry, similarly to a case described by Ramasamy et al 11 As previously reported, 82% of ACTH-secreting phaeochromocytomas occur in women, 61% in the left adrenal gland with a median age of 50 years at diagnosis and 83% prevalence of hypokalaemia, which is how our patient presented. 3,7 ACTH-induced hypercortisolism saturated mineralocorticoid receptors in our patient, causing low renin and hypokalaemia, but aldosterone was unusually elevated at presentation, likely explained by the paracrine effects of ACTH produced by the tumour.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…Similar presentations of hypertension, refractory to treatment, with Cushingoid features have been reported previously. 2,6,7 Phaeochromocytoma was suspected by unilaterally elevated levels of methoxycatecholamines on AVS but confirmed through immunohistochemistry, similarly to a case described by Ramasamy et al 11 As previously reported, 82% of ACTH-secreting phaeochromocytomas occur in women, 61% in the left adrenal gland with a median age of 50 years at diagnosis and 83% prevalence of hypokalaemia, which is how our patient presented. 3,7 ACTH-induced hypercortisolism saturated mineralocorticoid receptors in our patient, causing low renin and hypokalaemia, but aldosterone was unusually elevated at presentation, likely explained by the paracrine effects of ACTH produced by the tumour.…”
Section: Discussionsupporting
confidence: 86%
“…1 Excess pituitary secretion of ACTH accounts for 80-90% of ACTHdependent cases whilst ectopic secretion of ACTH accounts for 10-20% with the commonest sources originating from bronchial neuroendocrine tumour, medullary thyroid cancer or small cell lung cancer. 2,3 An ACTH-secreting phaeochromocytoma was first reported in 1964 and thought to be rare but is now found to occur in 3-25% of cases with ectopic ACTH-secretion. [4][5][6] There are likely <100 cases of ACTH-secreting phaeochromocytoma reported worldwide.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cushing's syndrome occurs in 0.7-2.4 cases per million population per year (1). The majority (80%) of cases are ACTH driven, while 20% of the cases are ACTH independent, where the primary abnormality is in the adrenal gland (3). Around 80% of ACTH-dependent cases are estimated to arise from the pituitary gland (Cushing's disease) and the remainder is due to ectopic production of ACTH (4).…”
Section: Discussionmentioning
confidence: 99%
“…Dexamethasone and betamethasone, which have high glucocorticoid potency and long duration of action, are more likely to induce a pheochromocytoma crisis. Thus, in patients with adrenal incidentalomas, glucocorticoids should be avoided or administered cautiously especially if the suspicion for pheochromocytoma is high (208). However, if dexamethasone suppression test is considered necessary before ruling out pheochromocytoma, the endocrinologist should preferably proceed with the overnight dexamethasone suppression protocol, as no cases of pheochromocytoma crisis have been reported, as yet, with this dose (209).…”
Section: Drug-induced Phaeo Crisismentioning
confidence: 99%